المساهمون: Jungsin Park, Choon Ok Kim, Eun Sil Oh, Jung Il Lee, Ja Kyung Kim, Sang Hoon Ahn, Do Young Kim, Seung Up Kim, Beom Kyung Kim, Yong Eun Chung, Se-Mi Kim, Min Soo Park, Kim, Do Young

مصطلحات موضوعية: Humans, Hypoglycemic Agents / pharmacokinetics, Liver Diseases, Pyrimidines / adverse effects, Thiazolidinediones* / pharmacokinetics, hepatic impairment, lobeglitazone, pharmacokinetics, safety, thiazolidinediones

العلاقة: CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT; J04263; OAK-2022-10554; OAK-2022-10555; OAK-2022-10556; OAK-2022-10557; OAK-2022-10558; OAK-2022-10559; OAK-2022-10560; OAK-2022-10561; OAK-2022-10562; https://ir.ymlib.yonsei.ac.kr/handle/22282913/194471Test; T9992023129; CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, Vol.11(5) : 576-584, 2022-05

الإتاحة: https://doi.org/10.1002/cpdd.1045Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/194471Test

المساهمون: Hiroshi Handa, June-Won Cheong, Yasushi Onishi, Hiroatsu Iida, Yukio Kobayashi, Hyeoung-Joon Kim, Tzeon-Jye Chiou, Koji Izutsu, Olga Tsukurov, Xiaofei Zhou, Helene Faessel, Ying Yuan, Farhad Sedarati, Douglas V Faller, Akiko Kimura, Shang-Ju Wu, Cheong, June Won

مصطلحات موضوعية: Adult, Azacitidine / therapeutic use, Cyclopentanes* / adverse effects, Cyclopentanes* / pharmacokinetics, Drug Therapy, Combination / adverse effects, Humans, Leukemia, Myeloid, Acute* / drug therapy, Myelodysplastic Syndromes* / drug therapy, Pyrimidines* / adverse effects, Pyrimidines* / pharmacokinetics, AML, East Asian, MDS, Pevonedistat, Phase 1/1b

العلاقة: JOURNAL OF HEMATOLOGY & ONCOLOGY; J01439; OAK-2022-05988; https://ir.ymlib.yonsei.ac.kr/handle/22282913/191389Test; T202204505; JOURNAL OF HEMATOLOGY & ONCOLOGY, Vol.15(1) : 56, 2022-05

الإتاحة: https://doi.org/10.1186/s13045-022-01264-wTest
https://ir.ymlib.yonsei.ac.kr/handle/22282913/191389Test

المساهمون: Xiuning Le, Hiroshi Sakai, Enriqueta Felip, Remi Veillon, Marina Chiara Garassino, Jo Raskin, Alexis B Cortot, Santiago Viteri, Julien Mazieres, Egbert F Smit, Michael Thomas, Wade T Iams, Byoung Chul Cho, Hye Ryun Kim, James Chih-Hsin Yang, Yuh-Min Chen, Jyoti D Patel, Christine M Bestvina, Keunchil Park, Frank Griesinger, Melissa Johnson, Maya Gottfried, Christian Britschgi, John Heymach, Elif Sikoglu, Karin Berghoff, Karl-Maria Schumacher, Rolf Bruns, Gordon Otto, Paul K Paik, Kim, Hye Ryun

مصطلحات موضوعية: Aged, Antineoplastic Agents / adverse effects, Brain Neoplasms* / drug therapy, Brain Neoplasms* / genetics, Carcinoma, Non-Small-Cell Lung* / drug therapy, Non-Small-Cell Lung* / genetics, Non-Small-Cell Lung* / pathology, Cohort Studies, Exons, Humans, Lung Neoplasms* / drug therapy, Lung Neoplasms* / genetics, Lung Neoplasms* / pathology, Piperidines* / adverse effects, Pyridazines* / adverse effects, Pyrimidines* / adverse effects, Retrospective Studies

العلاقة: CLINICAL CANCER RESEARCH; J00564; OAK-2022-05736; OAK-2022-05737; https://ir.ymlib.yonsei.ac.kr/handle/22282913/191279Test; T202205344; CLINICAL CANCER RESEARCH, Vol.28(6) : 1117-1126, 2022-03

الإتاحة: https://doi.org/10.1158/1078-0432.CCR-21-2733Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/191279Test

المؤلفون: Layoun, Michael E, Wickramasinghe, Chanaka D, Peralta, Maria V, Yang, Eric H

المصدر: Current oncology reports. 18(6)

مصطلحات موضوعية: Animals, Antineoplastic Agents: adverse effects, Cardiotoxicity: etiology, prevention & control, Cardiotoxins: adverse effects, Cardiovascular Diseases: chemically induced, prevention & control, Disease Management, Humans, Neoplasms: complications, drug therapy, Pyrimidines: adverse effects

وصف الملف: application/pdf

الوصول الحر: https://escholarship.org/uc/item/6db47672Test

المساهمون: Baek-Yeol Ryoo, Ann-Li Cheng, Zhenggang Ren, Tae-You Kim, Hongming Pan, Kun-Ming Rau, Hye Jin Choi, Joong-Won Park, Jee Hyun Kim, Chia Jui Yen, Ho Yeong Lim, Dongli Zhou, Josef Straub, Juergen Scheele, Karin Berghoff, Shukui Qin, Choi, Hye Jin

مصطلحات موضوعية: Administration, Oral, Adult, Aged, Asians / genetics, Carcinoma, Hepatocellular / drug therapy, Hepatocellular / genetics, Drug Administration Schedule, Female, Humans, Liver Neoplasms / drug therapy, Liver Neoplasms / genetics, Male, Middle Aged, Piperidines / administration & dosage, Piperidines / adverse effects, Proto-Oncogene Proteins c-met / genetics, Pyridazines / administration & dosage, Pyridazines / adverse effects, Pyrimidines / administration & dosage, Pyrimidines / adverse effects, Sorafenib / administration & dosage, Sorafenib / adverse effects, Survival Analysis, Treatment Outcome, Up-Regulation

العلاقة: BRITISH JOURNAL OF CANCER; J00406; OAK-2022-05002; https://ir.ymlib.yonsei.ac.kr/handle/22282913/190868Test; T9992022279; BRITISH JOURNAL OF CANCER, Vol.125(2) : 200-208, 2021-07

الإتاحة: https://doi.org/10.1038/s41416-021-01380-3Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/190868Test

المساهمون: Hae-Young Lee, Kwang-Il Kim, Sang Hyun Ihm, Moo-Yong Rhee, Il Suk Sohn, Sungha Park, Eun-Seok Jeon, Jong-Min Song, Wook Bum Pyun, Ki-Chul Sung, Moo Hyun Kim, Sang-Hyun Kim, Seok-Yeon Kim, Shin-Jae Kim, Eung Ju Kim, Jinho Shin, Sung Yun Lee, Kook-Jin Chun, Jin-Ok Jeong, Shung Chull Chae, Ki Dong Yoo, Young Jin Choi, Yong Hwan Park, Cheol-Ho Kim, Park, Sung Ha

مصطلحات موضوعية: Aged, Antihypertensive Agents / adverse effects, Biphenyl Compounds* / adverse effects, Blood Pressure, Diuretics / therapeutic use, Double-Blind Method, Drug Therapy, Combination, Essential Hypertension* / drug therapy, Humans, Perindopril* / adverse effects, Pyrimidines* / adverse effects, Tetrazoles* / adverse effects, Treatment Outcome, angiotensin receptor blocker, angiotensin-converting enzyme inhibitor, elderly, fimasartan, hypertension, perindopril

العلاقة: CLINICAL THERAPEUTICS; J00614; OAK-2022-04453; https://ir.ymlib.yonsei.ac.kr/handle/22282913/190570Test; https://www.sciencedirect.com/science/article/pii/S0149291821003003Test; T202126182; CLINICAL THERAPEUTICS, Vol.43(10) : 1746-1756, 2021-10

الإتاحة: https://doi.org/10.1016/j.clinthera.2021.08.003Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/190570Test
https://www.sciencedirect.com/science/article/pii/S0149291821003003Test

المساهمون: Justin F Gainor, Giuseppe Curigliano, Dong-Wan Kim, Dae Ho Lee, Benjamin Besse, Christina S Baik, Robert C Doebele, Philippe A Cassier, Gilberto Lopes, Daniel S W Tan, Elena Garralda, Luis G Paz-Ares, Byoung Chul Cho, Shirish M Gadgeel, Michael Thomas, Stephen V Liu, Matthew H Taylor, Aaron S Mansfield, Viola W Zhu, Corinne Clifford, Hui Zhang, Michael Palmer, Jennifer Green, Christopher D Turner, Vivek Subbiah, Cho, Byoung Chul

مصطلحات موضوعية: Aged, Antineoplastic Agents / adverse effects, Antineoplastic Agents / therapeutic use, Biomarkers, Tumor / genetics, Carcinoma, Non-Small-Cell Lung / drug therapy, Non-Small-Cell Lung / genetics, Non-Small-Cell Lung / pathology, Female, Gene Fusion, Humans, Lung Neoplasms / drug therapy, Lung Neoplasms / genetics, Lung Neoplasms / pathology, Male, Middle Aged, Protein Kinase Inhibitors / adverse effects, Protein Kinase Inhibitors / therapeutic use, Proto-Oncogene Proteins c-ret / antagonists & inhibitors, Proto-Oncogene Proteins c-ret / genetics, Pyrazoles / adverse effects, Pyrazoles / therapeutic use, Pyridines / adverse effects, Pyridines / therapeutic use, Pyrimidines / adverse effects, Pyrimidines / therapeutic use, Time Factors, Treatment Outcome

العلاقة: LANCET ONCOLOGY; J02154; OAK-2021-05094; https://ir.ymlib.yonsei.ac.kr/handle/22282913/184725Test; https://www.sciencedirect.com/science/article/pii/S1470204521002473Test; T202103493; LANCET ONCOLOGY, Vol.22(7) : 959-969, 2021-07

الإتاحة: https://doi.org/10.1016/S1470-2045Test(21)00247-3
https://ir.ymlib.yonsei.ac.kr/handle/22282913/184725Test
https://www.sciencedirect.com/science/article/pii/S1470204521002473Test

المؤلفون: Gueneau de Mussy, P., Sidharta, P.N., Wuerzner, G., Maillard, M.P., Guérard, N., Iglarz, M., Flamion, B., Dingemanse, J., Burnier, M.

المصدر: Clinical pharmacology and therapeutics, vol. 109, no. 3, pp. 746-753

مصطلحات موضوعية: Administration, Oral, Adult, Aldosterone/blood, Body Water/metabolism, Cross-Over Studies, Double-Blind Method, Endothelin Receptor Antagonists/administration & dosage, Endothelin Receptor Antagonists/adverse effects, Glycopeptides/blood, Healthy Volunteers, Homeostasis, Humans, Male, Middle Aged, Natriuresis/drug effects, Pyrimidines/administration & dosage, Pyrimidines/adverse effects, Sodium, Dietary/adverse effects, Sulfonamides/administration & dosage, Sulfonamides/adverse effects, Switzerland, Uric Acid/blood, Water-Electrolyte Balance/drug effects, Weight Gain/drug effects, Young Adult

وصف الملف: application/pdf

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/32897570; info:eu-repo/semantics/altIdentifier/eissn/1532-6535; info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_1BE20415C0D58; https://serval.unil.ch/notice/serval:BIB_1BE20415C0D5Test; urn:issn:0009-9236; https://serval.unil.ch/resource/serval:BIB_1BE20415C0D5.P001/REF.pdfTest; http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_1BE20415C0D58Test

الإتاحة: https://doi.org/10.1002/cpt.2043Test
https://serval.unil.ch/notice/serval:BIB_1BE20415C0D5Test
https://serval.unil.ch/resource/serval:BIB_1BE20415C0D5.P001/REF.pdfTest
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_1BE20415C0D58Test

المؤلفون: Dimopoulos, Meletios, Sanz, Ramon Garcia, Lee, Hui-Peng, Trneny, Marek, Varettoni, Marzia, Opat, Stephen, D'Sa, Shirley, Owen, Roger G., Cull, Gavin, Mulligan, Stephen, Czyz, Jaroslaw, Castillo, Jorge J., Motta, Marina, Siddiqi, Tanya, Gironella Mesa, Mercedes, Granell Gorrochategui, Miquel, Talaulikar, Dipti, Zinzani, Pier Luigi, Askari, Elham, Grosicki, Sebastian, Oriol, Albert, Rule, Simon, Kloczko, Janusz, Tedeschi, Alessandra, Buske, Christian, Leblond, Veronique, Trotman, Judith, Chan, Wai Y., Michel, Jan, Schneider, Jingjing, Tan, Ziwen, Cohen, Aileen, Huang, Jane, Tam, Constantine S.

مصطلحات موضوعية: Humans, Myeloid Differentiation Factor 88/genetics, Waldenstrom Macroglobulinemia/drug therapy/genetics, Piperidines, Pyrazoles/adverse effects, Pyrimidines/adverse effects

العلاقة: https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/33284944Test/; Dimopoulos, M. et al. (2020) 'Zanubrutinib for the treatment of MYD88 wild-type Waldenström macroglobulinemia: a substudy of the phase 3 ASPEN trial.', Blood advances, 4(23), pp. 6009-6018. doi:10.1182/bloodadvances.2020003010.; https://rde.dspace-express.com/handle/11287/621842Test; Blood advances; PMC7724905

الإتاحة: https://doi.org/10.1182/bloodadvances.2020003010Test
https://rde.dspace-express.com/handle/11287/621842Test

المؤلفون: Lenz, Georg, Hawkes, Eliza, Verhoef, Gregor, Haioun, Corinne, Thye Lim, Soon, Seog Heo, Dae, Ardeshna, Kirit, Chong, Geoffrey, Haaber, Jacob, Shi, Wei, Gorbatchevsky, Igor, Lippert, Susanne, Hiemeyer, Florian, Piraino, Paolo, Beckmann, Georg, Peña, Carol, Buvaylo, Viktoriya, Childs, Barrett H., Salles, Gilles

المصدر: http://lobid.org/resources/99370672770606441Test#!, 34(8):2184-2197.

مصطلحات موضوعية: CD79 Antigens/genetics [MeSH], Female [MeSH], Mutation [MeSH], Aged, 80 and over [MeSH], Lymphoma, Large B-Cell, Diffuse/genetics [MeSH], Aged [MeSH], Diffuse/drug therapy [MeSH], Adult [MeSH], Humans [MeSH], Middle Aged [MeSH], Quinazolines/adverse effects [MeSH], Recurrence [MeSH], Article, Pyrimidines/therapeutic use [MeSH], Male [MeSH], Pyrimidines/adverse effects [MeSH], B-cell lymphoma, Phosphoinositide-3 Kinase Inhibitors/therapeutic use [MeSH], Targeted therapies, Diffuse/mortality [MeSH], Quinazolines/therapeutic use [MeSH], High-Throughput Nucleotide Sequencing [MeSH]

العلاقة: https://repository.publisso.de/resource/frl:6471026Test; https://doi.org/10.1038/s41375-020-0743-yTest; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387311Test/

الإتاحة: https://doi.org/10.1038/s41375-020-0743-yTest
https://repository.publisso.de/resource/frl:6471026Test
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387311Test/